Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
2000 2
2001 6
2002 2
2003 4
2004 8
2005 3
2006 1
2007 4
2009 6
2010 3
2011 3
2012 2
2013 2
2014 5
2015 1
2016 3
2017 3
2018 4
2019 2
2020 4
2021 2
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

65 results
Results by year
Filters applied: . Clear all
Page 1
[Hypercalcemia].
Vielhauer V. Vielhauer V. MMW Fortschr Med. 2021 Sep;163(16):50-51. doi: 10.1007/s15006-021-0238-4. MMW Fortschr Med. 2021. PMID: 34533729 Review. German. No abstract available.
Intensive Supportive Care plus Immunosuppression in IgA Nephropathy.
Rauen T, Eitner F, Fitzner C, Sommerer C, Zeier M, Otte B, Panzer U, Peters H, Benck U, Mertens PR, Kuhlmann U, Witzke O, Gross O, Vielhauer V, Mann JF, Hilgers RD, Floege J; STOP-IgAN Investigators. Rauen T, et al. Among authors: vielhauer v. N Engl J Med. 2015 Dec 3;373(23):2225-36. doi: 10.1056/NEJMoa1415463. N Engl J Med. 2015. PMID: 26630142 Free article. Clinical Trial.
After ten years of follow-up, no difference between supportive care plus immunosuppression and supportive care alone in IgA nephropathy.
Rauen T, Wied S, Fitzner C, Eitner F, Sommerer C, Zeier M, Otte B, Panzer U, Budde K, Benck U, Mertens PR, Kuhlmann U, Witzke O, Gross O, Vielhauer V, Mann JFE, Hilgers RD, Floege J; STOP-IgAN Investigators. Rauen T, et al. Among authors: vielhauer v. Kidney Int. 2020 Oct;98(4):1044-1052. doi: 10.1016/j.kint.2020.04.046. Epub 2020 May 22. Kidney Int. 2020. PMID: 32450154 Clinical Trial.
Effects of Two Immunosuppressive Treatment Protocols for IgA Nephropathy.
Rauen T, Fitzner C, Eitner F, Sommerer C, Zeier M, Otte B, Panzer U, Peters H, Benck U, Mertens PR, Kuhlmann U, Witzke O, Gross O, Vielhauer V, Mann JFE, Hilgers RD, Floege J. Rauen T, et al. Among authors: vielhauer v. J Am Soc Nephrol. 2018 Jan;29(1):317-325. doi: 10.1681/ASN.2017060713. Epub 2017 Oct 17. J Am Soc Nephrol. 2018. PMID: 29042456 Free PMC article. Clinical Trial.
Renal co-morbidity in patients with rheumatic diseases.
Anders HJ, Vielhauer V. Anders HJ, et al. Among authors: vielhauer v. Arthritis Res Ther. 2011 Jun 29;13(3):222. doi: 10.1186/ar3256. Arthritis Res Ther. 2011. PMID: 21722341 Free PMC article. Review.
Extratubular Polymerized Uromodulin Induces Leukocyte Recruitment and Inflammation In Vivo.
Immler R, Lange-Sperandio B, Steffen T, Beck H, Rohwedder I, Roth J, Napoli M, Hupel G, Pfister F, Popper B, Uhl B, Mannell H, Reichel CA, Vielhauer V, Scherberich J, Sperandio M, Pruenster M. Immler R, et al. Among authors: vielhauer v. Front Immunol. 2020 Dec 22;11:588245. doi: 10.3389/fimmu.2020.588245. eCollection 2020. Front Immunol. 2020. PMID: 33414784 Free PMC article.
Cytotoxicity of crystals involves RIPK3-MLKL-mediated necroptosis.
Mulay SR, Desai J, Kumar SV, Eberhard JN, Thomasova D, Romoli S, Grigorescu M, Kulkarni OP, Popper B, Vielhauer V, Zuchtriegel G, Reichel C, Bräsen JH, Romagnani P, Bilyy R, Munoz LE, Herrmann M, Liapis H, Krautwald S, Linkermann A, Anders HJ. Mulay SR, et al. Among authors: vielhauer v. Nat Commun. 2016 Jan 28;7:10274. doi: 10.1038/ncomms10274. Nat Commun. 2016. PMID: 26817517 Free PMC article.
65 results